Mincheng Yu

968 total citations
32 papers, 453 citations indexed

About

Mincheng Yu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mincheng Yu has authored 32 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Mincheng Yu's work include Cancer Immunotherapy and Biomarkers (9 papers), MicroRNA in disease regulation (6 papers) and Cancer Mechanisms and Therapy (4 papers). Mincheng Yu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), MicroRNA in disease regulation (6 papers) and Cancer Mechanisms and Therapy (4 papers). Mincheng Yu collaborates with scholars based in China, Ethiopia and Taiwan. Mincheng Yu's co-authors include Qing‐Hai Ye, Jia Fan, Binghai Zhou, Jiuliang Yan, Yong‐Sheng Xiao, Yongfeng Xu, Zheng Chen, Zhangfu Yang, Lei Guo and Bo Hu and has published in prestigious journals such as Cancer Research, Oncogene and Gut.

In The Last Decade

Mincheng Yu

28 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mincheng Yu China 14 232 160 130 111 89 32 453
Hanzhang Zhu China 11 180 0.8× 115 0.7× 103 0.8× 87 0.8× 78 0.9× 18 377
Shuzhen Chen China 10 234 1.0× 147 0.9× 109 0.8× 73 0.7× 77 0.9× 13 481
Jiunn-Chang Lin Taiwan 11 150 0.6× 79 0.5× 152 1.2× 124 1.1× 84 0.9× 27 426
Yuqiang Shan China 9 178 0.8× 112 0.7× 81 0.6× 63 0.6× 82 0.9× 30 359
Changku Jia China 10 238 1.0× 91 0.6× 115 0.9× 81 0.7× 55 0.6× 22 427
Reid Loveless United States 11 332 1.4× 137 0.9× 85 0.7× 127 1.1× 94 1.1× 14 507
Songping Xie China 15 349 1.5× 220 1.4× 134 1.0× 90 0.8× 90 1.0× 40 579
Shaocong Wu China 10 255 1.1× 130 0.8× 199 1.5× 96 0.9× 80 0.9× 14 454
Pian Liu China 13 317 1.4× 135 0.8× 114 0.9× 45 0.4× 65 0.7× 29 533
Cerise Yuen‐Ki Chan Hong Kong 10 403 1.7× 232 1.4× 103 0.8× 66 0.6× 162 1.8× 12 576

Countries citing papers authored by Mincheng Yu

Since Specialization
Citations

This map shows the geographic impact of Mincheng Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mincheng Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mincheng Yu more than expected).

Fields of papers citing papers by Mincheng Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mincheng Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mincheng Yu. The network helps show where Mincheng Yu may publish in the future.

Co-authorship network of co-authors of Mincheng Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Mincheng Yu. A scholar is included among the top collaborators of Mincheng Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mincheng Yu. Mincheng Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Mincheng, Peiyi Xie, Wenxin Xu, et al.. (2025). Liver regeneration–associated hepatocellular YAP1 activation prevents colorectal cancer liver metastasis through glutamine competition. Science Advances. 11(34). eadw6926–eadw6926.
2.
3.
Weng, Jialei, Mincheng Yu, Qiang Yu, et al.. (2025). Galectin-4 drives anti-PD-L1/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma. Gut. 75(3). 620–634. 1 indexed citations
4.
Huang, Da, Min Xu, Hui Wang, et al.. (2025). SIRPα blockade therapy potentiates immunotherapy by inhibiting PD-L1+ myeloid cells in hepatocellular carcinoma. Cell Death and Disease. 16(1). 451–451.
5.
Xie, Peiyi, Mincheng Yu, Mengyuan Wu, et al.. (2024). ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis. Cancer Research. 85(2). 299–313. 11 indexed citations
6.
Xie, Peiyi, Hui Wang, Bo Zhang, et al.. (2024). GOLM1 dictates acquired Lenvatinib resistance by a GOLM1-CSN5 positive feedback loop upon EGFR signaling activation in hepatocellular carcinoma. Oncogene. 43(42). 3108–3120. 3 indexed citations
7.
Chen, Zheng, Mincheng Yu, Bo Zhang, et al.. (2024). SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion. OncoImmunology. 13(1). 2376264–2376264. 3 indexed citations
8.
Yu, Mincheng, et al.. (2023). Failure of Elliptical Tubes with Different Long–Short Axis Ratios under Cyclic Bending in Different Directions. Metals. 13(11). 1891–1891. 2 indexed citations
9.
Jin, Lei, Ju Huang, Lei Guo, et al.. (2023). CYP1B1 promotes colorectal cancer liver metastasis by enhancing the growth of metastatic cancer cells via a fatty acids-dependent manner. Journal of Gastrointestinal Oncology. 14(6). 2448–2465. 6 indexed citations
10.
Xie, Peiyi, Jiuliang Yan, Hui Li, et al.. (2022). CD44 potentiates hepatocellular carcinoma migration and extrahepatic metastases via the AKT/ERK signaling CXCR4 axis. Annals of Translational Medicine. 10(12). 689–689. 13 indexed citations
11.
Zhou, Qiang, Yirui Yin, Mincheng Yu, et al.. (2022). GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism. Redox Biology. 56. 102458–102458. 55 indexed citations
12.
Chen, Zheng, Shuang Liu, Peiyi Xie, et al.. (2022). Tumor-derived PD1 and PD-L1 could promote hepatocellular carcinoma growth through autophagy induction in vitro. Biochemical and Biophysical Research Communications. 605. 82–89. 21 indexed citations
13.
Yu, Mincheng, Guangyu Ding, Peng Ma, et al.. (2021). CircRNA UBAP2 serves as a sponge of miR-1294 to increase tumorigenesis in hepatocellular carcinoma through regulating c-Myc expression. Carcinogenesis. 42(10). 1293–1303. 22 indexed citations
14.
Hu, Bo, Xiaolu Ma, Pei‐Yao Fu, et al.. (2021). The mRNA–miRNA–lncRNA Regulatory Network and Factors Associated with Prognosis Prediction of Hepatocellular Carcinoma. Genomics Proteomics & Bioinformatics. 19(6). 913–925. 20 indexed citations
15.
16.
Sun, Haixiang, Zhangfu Yang, Ai‐Wu Ke, et al.. (2020). MicroRNA-19a-3p regulates cell growth through modulation of the PIK3IP1-AKT pathway in hepatocellular carcinoma. Journal of Cancer. 11(9). 2476–2484. 17 indexed citations
17.
Yu, Mincheng, et al.. (2020). QSOX1 promotes mitochondrial apoptosis of hepatocellular carcinoma cells during anchorage-independent growth by inhibiting lipid synthesis. Biochemical and Biophysical Research Communications. 532(2). 258–264. 7 indexed citations
18.
Fu, Pei‐Yao, Bo Hu, Xiaolu Ma, et al.. (2019). Far upstream element-binding protein 1 facilitates hepatocellular carcinoma invasion and metastasis. Carcinogenesis. 41(7). 950–960. 13 indexed citations
19.
Fu, Pei‐Yao, Bo Hu, Xiaolu Ma, et al.. (2018). New insight into BIRC3: A novel prognostic indicator and a potential therapeutic target for liver cancer. Journal of Cellular Biochemistry. 120(4). 6035–6045. 34 indexed citations
20.
Wang, Xun, et al.. (1990). RHEED intensity oscillations of mbe grown Ge/Si ultra-thin multi-layered structures. Surface Science. 228(1-3). 334–339. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hanzhang Zhu Breakdown of academic impact, for papers by Shuzhen Chen Breakdown of academic impact, for papers by Jiunn-Chang Lin Breakdown of academic impact, for papers by Yuqiang Shan Breakdown of academic impact, for papers by Changku Jia Breakdown of academic impact, for papers by Reid Loveless Breakdown of academic impact, for papers by Songping Xie Breakdown of academic impact, for papers by Shaocong Wu Breakdown of academic impact, for papers by Pian Liu Breakdown of academic impact, for papers by Cerise Yuen‐Ki Chan
Rankless by CCL
2026